INTRODUCTION
Barley (Hordeum vulgare L.) is one of the most commonly cultivated cereals worldwide (ca. 30% of the world grain production). Most barley crops are produced in Europe, Asia, and North Africa. Barley is widely used as a dietary supplement, a raw material in baking and brewing, animal fodder, as well as a drug in traditional folk medicine (Japanese barley tea) [1, 2] .
Barley grains contain a high concentration of carbohydrates, such as starch (65-68%) and dietary fibre (11-34%), proteins (10-17%), β-glucans, (4-9%, generally β-(1,3/1,4)-glucan), some free lipids (2-3%), minerals (1.5-2.5%), and vitamins [1] . However, it has been shown that grass extracts usually contain a higher concentration of proteins (45.2%) than carbohydrates (23.2%) and lipids (3.2%) [3] . Moreover, young barley grass can be a good source of dietary minerals (especially sodium, magnesium, iron, copper, and phosphorous) and vitamins (thiamine, riboflavin, tocopherols and tocotrienols, biotin, folic acid, and pantothenic acid), which are richer than those found in some popular vegetables (spinach, tomato, lettuce), fruits (banana), dairy products (cow's milk), and fish (canned salmon) [3] . Furthermore, young barley grass has a high content of glucose (15.4-88.4 g/kg dry weight), fructose (37.6-81.4 g/kg dry weight), aspartic acid (15.23-28 .68 g/kg dry weight), glutamic acid (16.69-35.52 g/kg dry weight), and ascorbic acid [4] . Interestingly, many different phenolic compounds including flavones (e.g. major leaf antioxidants, such as saponarin, lutonarin, and 2-O-glucosylvitexin), leucoanthocyanidins, catechins, and coumarins have been found in young barley extracts. The total level of polyphenolic compounds in barley grass varies from 857 -1,690 mg/kg dry mass [5] and one of them -5,7-dihydroxyflavone -tricin, has been characterized as a melanin biosynthesis inhibitor [6] .
Besides phenolic compounds, some chemopreventive barley proteins have been described in literature. Lunasin, a 43-amino-acid peptide isolated from barley, inhibited tumorigenesis in ras-transfected mouse fibroblasts treated with isopropyl-β-d-thiogalactoside (IPTG) [7] .
Clinical studies have shown that young barley-containing products may lower blood pressure and reduce the risk of coronary heart disease [8] , decrease the serum cholesterol level [9] , lower the risk of Type 2 diabetes, reduce symptoms of rheumatoid arthritis, accelerate body tissue repair, and help to prevent gallstone formation [2] . Furthermore, there is ample evidence that young barley possesses immunostimulatory [10] , anticancer [11, 12] , antidepressant-like [13] , prebiotic [14] , and antiulcer properties [15] . In other studies, it has been revealed that, barley consumption may improve human organism disorders like improper body weight, liver injury, allergy, body odour, wrinkles, and tired skin [3] .
Despite the development of medicine, one in four deaths in industrialized countries is due to cancer. Lung cancer is the most commonly diagnosed cancer disease and the main cause of death globally. The major factors associated with development of lung cancer include tobacco smoking, heavy air pollution, and exposition to carcinogens such as asbestos, arsenic, radon, or polycyclic aromatic hydrocarbons [16, 17] . In turn, the third most commonly diagnosed and the second in terms of worldwide mortality is colorectal cancer (CRC) [18] . There are several factors associated with the development of CRC, e.g. diet high in animal fat and red meat, together with low intake of fruits and vegetables, environmental risk factors, low physical activity, obesity, and heavy alcohol consumption [19, 20, 21] .
OBJECTIVES
Based on the broad spectrum of beneficial compounds present in young barley, the aim of the present study was an in vitro evaluation of the anticancer potential of its extracts in a colon and lung carcinoma cell culture model. Cell proliferation -MTT assay. The metabolic activity of growing cells was assessed by means of the MTT assay. In the test, yellow tetrazolium salt MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide -Sigma) is metabolized by viable cells to purple formazan crystals. HT-29 and A549 cells were plated on flat-bottom 96-well microplates at a density of 3 х 10 4 cells/ml (HT-29) and 1 х 10 4 (A549) cells/ml in 100 μl of a complete growth medium. The next day, the culture medium was removed and the cells exposed to serial dilutions of HWE and HJE at concentrations ranging from 0.1 -5 mg/ml. After 96-hour incubation, the cells were incubated for 3 h with an MTT solution (5 mg ⁄ml), and formazan crystals then solubilized overnight by adding SDS buffer (10% SDS in 0.01 N HCl). The colour product of the reaction was quantified by measuring absorbance at a 570 nm wavelength using an Emax Miocroplate Reader (Menlo Park, CA, USA). IC 50 was calculated using the computerized linear regression analysis of quantal log dose-probit functions, according to the method of Litchfield and Wilcoxon. Cell proliferation (%) was expressed as a percentage relative to the untreated control cells [22] .
MATERIALS AND METHOD

Barley
Cell viability -Neutral Red (NR) assay. The neutral red assay determines the accumulation of neutral red dye in the lysosomes of viable, uninjured cells. The HT-29, CCD 841 CoTr, A549, and HSF cells were plated on 96-well microplates at a density of 1 х 10 5 cells/ml in a complete growth medium. After 24-hour incubation, the growth medium was replaced by a fresh medium (containing 2% FBS) and the cells exposed to serial dilutions of HWE and HJE (0.1-5 mg/ml). After 24 h, the cells were incubated with the NR reagent for 3 h, fixed with the NR fixative solution (1% CaCl 2 in 0.5% formalin) for 3 min at room temperature, and solubilized in 1% acetic acid in 50% ethanol under shaking for 20 min. Absorbance was measured at 550 nm using an Emax Miocroplate Reader [23] .
Necrosis and apoptosis detection -Propidium iodide and
Hoechst 33342 solution staining. The staining mixture of propidium iodide (PI) (Sigma) stains cells with damaged cytoplasmic membrane (necrosis) in red. Hoechst 33342 (Sigma) stains uninjured non-apoptotic cells in blue and condensed chromatin of apoptotic cells in bright blue. The HT-29 and A549 cells were plated on cell culture Petri dishes (Nunc) at a density of 5 х 10 4 cells/ml. The next day, the cells were exposed to 0.25; 0.5; and 0.75 mg/ml of HWE for 24 h and 48 h (37ºC; 5% CO 2 ). Next, the medium was removed and the cells washed with 0.5 ml of pre-warmed PBS, followed by incubation with the staining solution [propidium iodide (0.15 mg/ml), and Hoechst 33342 (0.24 mg/ml) in a serumfree culture medium] in darkness for 5 min. The percentage of apoptotic and necrotic cells was assessed with Confocal Microscopy using a Nikon Eclipse Ti microscope and the NIS-Elements (Nikon) and ImageJ software (developed by Wayne Rasband) [24] .
Cell cycle progression -Propidium iodide staining. Propidium iodide (PI) staining is a method for analysis of cellular DNA content by flow cytometry. The HT-29 and A549 cells were seeded on 6-well microplates at a density of 5 х 10 5 cells/ml. After 24-h incubation, the cells were exposed to 0.5; 1; 2.5; 5; and 7.5 mg/ml of the HWE for the next 24 h (at 37ºC and 5% CO 2 ). Next, the medium was removed and, the cells washed with PBS and collected in a 5 mM EDTA/PBS solution. After centrifugation (10 min; 1,500 rpm [239×g]), the cells were fixed with 70% ice-cold ethanol and then stored at -20ºC. PI/RNase (BD) staining was performed directly before flow cytometric (BD FACSCalibur) analysis. The PI fluorescence intensity of individual nuclei was determined and at least 10,000 events were measured within an acquisition rate >60 events/sec. Cell cycle analyses were performed with the use of software CellQuest Pro Version 6.0. for Macintosh operating system [25] .
Free radical scavenging activity -DPPH assay. The free radical scavenging activity of HWE and HJE was measured with the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay. This method is based on the ability of antioxidants to reduce the stable dark violet radical DPPH (Sigma) to the yellow colored diphenyl-picrylhydrazine. Briefly, 100 μl of the DPPH solution (0.2 mg/ml in ethanol) were added to standards and to 100 μl of 0.1; 0.25; 0.5; 0.75; 1; 2.5; and 5 mg/ml HWE and HJE. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid -Sigma) at increasing concentrations (1-50 μg/ml) was used as a standard for free radical scavenging activity. After 20 min. incubation at room temperature, the absorbance of the solution was measured at 515 nm. The lower the absorbance, the higher the free radical scavenging activity of the extracts. The activity of each extract was determined by comparing its absorbance with that of a control solution (reagents without extract) and standards. The capability to scavenge DPPH radical was calculated by the following formula: DPPH scavenging effect (%) = [(Xcontrol − Xextract/Xcontrol) × 100] where Xcontrol is the absorbance of the control and Xextract is the absorbance in the presence of extracts [23] .
Statistical analysis. The data were expressed as means ± standard deviation. Statistical analyses were performed using GraphPad Prism 5.0 (GraphPad Software Inc., CA, USA). The data were analyzed by one-way ANOVA test, Tukey's Multiple Comparison Post-test; *p values <0.05, **p values <0.01, ***p values <0.001, were considered to be significant.
RESULTS AND DISCUSSION
The results are presented in Figures S1 -S4 and Table ST1 .
The presented study shows the anticancer potential of the young barley in both HT-29 (human colon adenocarcinoma) and A549 (human lung adenocarcinoma) cancer cells. In the first step, the antiproliferative effect of HWE and HJE was determined using an MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay. Both extracts exerted a dose-dependent antiproliferative effect in the HT-29 cells. After 96 h exposure, the highest concentration 5 mg/ml HWE and HJE decreased cell proliferation to 6.7% and 5.5% vs. control cells (Fig. S1A) . The IC 50 value [concentration causing proliferation inhibition by 50%] compared to control was calculated according to the Litchfield and Wilcoxon method [26] ; HWE and HJE were calculated at 0.7 mg/ml and 2.4 mg/ml, respectively. In the case of the A549 cells, the highest HWE and HJE concentrations also reduced cell proliferation to 22% and 62%, respectively (Fig. S1B) ; however, the IC 50 value of both extracts was higher (1.3 mg/ml and 7.4 mg/ml, respectively) compared to that for the HT-29 cells.
Recently, the antiproliferative potential of young barley extracts has been revealed in breast cancer cells [27] . In the study by Kubatka et al., the tested barley extract at the concentration 1 mg/ml decreased MCF-7 breast cancer cells proliferation to 37.93% after 72 h treatment. In order to verify the cytotoxicity of the extracts against normal and cancer cells, the NR (neutral red) cell viability assay was applied. The experiments showed that the colon carcinoma cells were more sensitive to the tested extracts (the IC 50 value of HWE and HJE was calculated at 9.3 mg/ml and 48.1 mg/ml, respectively) than the normal colon epithelial cells. The viability of the cancer cells was decreased in a dose-dependent fashion, whereas normal CCD841 CoTr cells were unaffected in the entire concentration range (HJE) and up to 2.5 mg/ml (HWE) (Fig. S2A, S2C ). Moreover, a significant increase in neutral red uptake was observed in normal cells, compared to the control cultures, which suggests protective or trophic properties. This phenomenon requires further studies in order to prove the beneficial effects of young barley in normal colon epithelium. Animal studies [28] have shown that young barley leaf powder shortened gastrointestinal transit time and decreased pH of the gut. This may lead to a decreased colorectal cancer risk by reduced carcinogen exposition time in the gut and suppression of Figure S1 . Influence of HWE and HJE on the proliferation of (A) HT-29 human colon adenocarcinoma, and (B) A549 human lung adenocarcinoma cell lines treated with the extracts at various concentrations for 96 h where ** indicates p<0.01 and *** p<0.001 local inflammation. It should also be noted that similar results were obtained [29] showing cytotoxicity of a barley water extract against human cervical JTC-26 cancer cells, but not against human normal embryonic cells (HE-1 line). In contrast, lung carcinoma A549 cells were not sensitive to both extracts in the entire concentration range tested. Moreover, a significant cytotoxic effect at a higher extract concentrations was observed in cultures of normal skin fibroblasts (Fig. S2B, S2D ). This may suggest tissue specificity of the tested young barley extracts. Because the HWE extract showed stronger anticancer activity, it was selected for further studies. To verify whether HWE induced necrotic or apoptotic cell death, differential staining of propidium iodide and Hoechst was applied. In the HT-29 cell culture, it was shown that 24 h exposure at concentrations 0.25, 0.5, and 0.75 mg/ml induced necrosis in 7.4%, 10.2%, and 11.2% cells, respectively. Furthermore, after 48 h, the level of necrotic cells increased to 14.7%, 20.4%, and 22.5%, respectively (Fig. S3 ). In the presented study, HWE did not induce apoptosis in the HT-29 cells. Further experiments showed that, in the case of the A549 lung carcinoma cells, the tested extract did not evoke any changes (data not shown). The results obtained confirm the specificity of the HWE extract against colon carcinoma cells.
The antioxidant activity is a very important feature of potential chemopreventive agents. Recently, the presence of a potent antioxidant flavonoid -saponarin -in young barley extracts has been described [30] . In the current study, the HWE extract within the concentration range of 0.1 -1 mg/ml showed a dose-dependent antioxidative activity in the DPPH (2,2-diphenyl-1-picrylhydrazyl) scavenging assay. The highest scavenging action was observed at 1 mg/ml, which is an equivalent of 33.6 µg/ml of Trolox activity (Fig. S4) . In contrast, no such activity was found in the case of the HJE extract (data not shown).
The inhibition of cancer cell cycle progression is very often described as one of the mechanisms of anticancer action. Such an activity of young barley was described by Kubatka in MCF-7 breast cancer cells [27] . In the presented study, no significant changes were observed in the HT-29 and A549 cells cell cycle progression after exposure to the HWE extract (Tab. ST1A, ST1B).
CONCLUSIONS
Initial studies revealed an anticancer potential of young barley in colon carcinoma cells. The observed effects were attributed to cancer cell proliferation inhibition, necrosis induction, and noticeable antioxidant activity. Of note is Table ST1 . Influence of HWE on percentage of cell population in each phase of the cell cycle of (A) HT-29 human colon adenocarcinoma, and (B) A549 human lung adenocarcinoma cell lines treated with the extract at various concentrations for 24 h. G 1 -G 1 cell cycle phase, S -S cell cycle phase, and G 2 -G 2 cell cycle phase A HT-29 cell cycle phases Control 0.5 mg/ml 1 mg/ml 2.5 mg/ml 5 mg/ml 7.5 mg/ml 
